Study on the Use of Sarilumab in Patients With COVID-19 Infection

NCT04386239 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Technical impasse from IRB

Conditions

COVID19

Interventions

DRUG: Sarilumab Prefilled Syringe

Sponsor

ASST Fatebenefratelli Sacco